TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,428 | -45.7% | 3,583 | -44.9% | 0.00% | – |
| Q2 2023 | $102,146 | +80.0% | 6,502 | +88.8% | 0.00% | – |
| Q1 2023 | $56,741 | +22.2% | 3,443 | +15.7% | 0.00% | – |
| Q4 2022 | $46,426 | +54.8% | 2,976 | +28.7% | 0.00% | – |
| Q3 2022 | $30,000 | -11.8% | 2,313 | -5.1% | 0.00% | – |
| Q2 2022 | $34,000 | -12.8% | 2,438 | -10.7% | 0.00% | – |
| Q1 2022 | $39,000 | +225.0% | 2,730 | +217.8% | 0.00% | – |
| Q4 2021 | $12,000 | -87.4% | 859 | -85.2% | 0.00% | – |
| Q3 2021 | $95,000 | +578.6% | 5,817 | +586.8% | 0.00% | – |
| Q2 2021 | $14,000 | -73.1% | 847 | -70.1% | 0.00% | – |
| Q1 2021 | $52,000 | +477.8% | 2,836 | +494.5% | 0.00% | – |
| Q4 2020 | $9,000 | -62.5% | 477 | -64.6% | 0.00% | – |
| Q3 2020 | $24,000 | +200.0% | 1,346 | +204.5% | 0.00% | – |
| Q2 2020 | $8,000 | -71.4% | 442 | -76.1% | 0.00% | – |
| Q1 2020 | $28,000 | +115.4% | 1,847 | +191.3% | 0.00% | – |
| Q4 2019 | $13,000 | -23.5% | 634 | -37.0% | 0.00% | – |
| Q3 2019 | $17,000 | -83.8% | 1,007 | -83.1% | 0.00% | – |
| Q2 2019 | $105,000 | -88.4% | 5,949 | -86.6% | 0.00% | -100.0% |
| Q1 2019 | $907,000 | – | 44,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |